Reckitt Benckiser plc / Schiff Nutrition International, Inc.

Vitamins, Minerals & Dietary Supplements (VMS / Consumer Health)

$30.0B Global VMS market 2012 (Reckitt/Kapoor cited)

Disease Overview

Vitamins, minerals and dietary supplements (VMS) are over-the-counter consumer-health products marketed for joint, heart, immune, and general wellness support. The category sits at the border between pharmacy and consumer packaged goods, regulated by FDA under DSHEA rather than as drugs, and is driven by branding, distribution, and consumer trust rather than clinical efficacy claims.

Competitive Landscape

The 2012 global VMS market was a $30B fragmented opportunity with no player above 5% share — a structural setup that made bolt-on M&A the fastest path to scale. Schiff's portfolio anchored on three category-leading brands: MegaRed (#1 in the heart-health omega segment), Move Free (#2 in joint care), and Airborne (#2 in immune support), plus the legacy Schiff Vitamins line, with FY2012 revenue of $259M (90% US) and FY2013 guidance to $385M. Bayer initially struck a deal at $34/share ($1.2B) on October 30, 2012, leveraging its One A Day and Aleve consumer-health platform. Reckitt Benckiser, fresh off its strategic pivot to global health and hygiene under CEO Rakesh Kapoor, jumped in with a $42/share ($1.4B) tender — a 23.5% premium that Bayer declined to match. The price drew criticism for the multiple paid, but analysts pointed to Reckitt's track record integrating Boots Healthcare, Adams (Mucinex), and SSL (Durex) as justification. The deal anchored Reckitt's US consumer-health platform alongside competitors Pfizer Consumer (Centrum), Pharmavite (Nature Made), NBTY, and Herbalife. (Sources: nutraingredients.com 2012-11-22; consumergoods.com.)